Start building today!
Experience the Find the courses and unlock the true potential
The Master of Philosophy (Experimental Pharmacology) is a research-focused postgraduate degree that trains students to investigate how drugs, chemicals, and biological agents interact with living systems at the molecular, cellular, and whole-organism level. Typically completed over two years of full-time study, the degree is structured around an original, supervised research project culminating in a thesis. Students delve into areas such as drug discovery, receptor pharmacology, neuropharmacology, cardiovascular pharmacology, toxicology, and the mechanisms by which drugs exert their therapeutic or adverse effects on tissues and organ systems. Rather than following a traditional coursework structure, this qualification is primarily research-driven, requiring students to design experiments, collect and analyse data, and contribute new knowledge to the scientific literature.
This degree is ideally suited to science graduates with a strong background in biomedical science, biochemistry, physiology, pharmacy, or a related discipline who wish to pursue a career in research, drug development, or academia. Students work closely with academic supervisors and often collaborate with research institutes, hospitals, and pharmaceutical companies. The qualification provides a pathway to doctoral study (PhD) or to professional roles in the pharmaceutical, biotechnology, and medical research sectors. Employers who value this qualification include pharmaceutical and biotechnology companies such as CSL Behring, AstraZeneca, Pfizer Australia, and Johnson & Johnson, as well as university research centres, government health agencies, hospital research institutes, contract research organisations (CROs), and medical device companies.
The experimental focus of the degree means graduates develop deep technical expertise in laboratory-based research methods, including cell culture, animal model studies, molecular biology techniques, high-throughput screening, and advanced data analysis. This distinguishes the MPhil (Experimental Pharmacology) from clinical or coursework pharmacy qualifications, making it a highly specialised research credential that is valued across both academic and industry settings in Australia.
Australia's pharmaceutical and biotechnology sector is a significant and growing contributor to the national economy, with demand for skilled pharmacological researchers continuing to rise. The Australian government actively supports research and development through grants, tax incentives, and industry partnerships, creating a fertile environment for scientific and pharmaceutical advancements. There is a recognised skills gap in highly trained experimental scientists who can bridge the gap between basic laboratory research and the development of safe, effective medicines — a gap that MPhil graduates in Experimental Pharmacology are uniquely positioned to fill. The global push to develop new treatments for chronic diseases, cancer, neurological disorders, and infectious diseases means that experimental pharmacologists with rigorous research training are in sustained demand across academia, industry, and government.
Studying this degree in Australia offers access to world-class research infrastructure, internationally recognised supervisors, and strong links to leading pharmaceutical companies and medical research institutes. Graduates emerge with a research credential that is globally portable, with Australian pharmaceutical and biotech companies known internationally for their high standards and innovation — meaning experience gained in Australia opens doors globally. The degree also serves as a direct pathway to a PhD, enabling ambitious students to pursue the highest levels of research leadership and discovery science.
To be considered for admission to an MPhil (Experimental Pharmacology) or equivalent research master's degree in Australia, applicants typically need to hold an Honours degree (Class 2A or higher) or a relevant Bachelor's degree with a strong academic record in a discipline such as pharmacology, biomedical science, biochemistry, physiology, pharmacy, or a closely related natural science. Some institutions also accept applicants who hold a relevant Master's degree by coursework with demonstrated research components. Meeting the minimum academic entry requirements does not automatically guarantee admission — applicants are generally assessed competitively, and securing the support of a suitable academic supervisor before formally applying is a critical first step at most institutions.
For international students, English language proficiency is required, with most Australian universities specifying a minimum IELTS overall score of 6.5 (with some programs, particularly those with clinical components, requiring 7.0 or above), or equivalent scores in TOEFL or PTE Academic. Applicants are generally required to submit a curriculum vitae, a research proposal or statement of research interest, academic transcripts, and referee reports from academic or research supervisors. Evidence of prior laboratory or research experience — while not always compulsory — significantly strengthens an application and is highly regarded by selection committees.
Course fees for international students in this category typically range from approximately AUD $42,000 to $52,000 per year (as of 2025–2026), though domestic students who qualify may be eligible for Research Training Program (RTP) fee offsets, which can significantly reduce or eliminate tuition costs. Scholarship opportunities, including RTP stipends and university-specific awards, are available and competitive for high-achieving domestic and international applicants.
This course may be offered in different study modes depending on the university, campus location, course structure and student type. Students should check the available delivery mode before applying, as not every study option is available at every institution.
On-campus study is the traditional mode of delivery where students attend classes, lectures, tutorials, workshops or seminars at the university campus. This option may suit students who prefer face-to-face learning, access to campus facilities, networking with classmates, practical workshops, group projects and direct engagement with academic staff.
Some universities may offer programs fully online or with online subject options. Online study can be attractive for students who need flexibility due to work, family, location or other commitments. Online study may suit domestic students, working professionals or students who want to study from outside Australia.
Hybrid or blended study usually combines online learning with some on-campus classes, workshops, intensive sessions or practical components. This mode may suit students who want flexibility but still want some face-to-face interaction. The exact structure varies between institutions.
Programs in Australia may have different intake structures depending on the university. The most common intake systems are semester, trimester and block mode.
Many Australian universities follow a two-semester academic calendar. The main intakes are commonly Semester 1 (around February or March) and Semester 2 (around July). Semester-based study usually allows students to complete a set number of subjects over approximately 12 to 14 weeks.
Some universities use a trimester system, which generally provides three study periods a year — around February/March, June/July and October/November. Trimester study may provide more flexibility and may help some students complete their course faster.
Some institutions may offer selected subjects or programs in block mode, where students focus on one subject at a time over a shorter, more intensive teaching period. Block mode may suit students who prefer concentrated learning or working professionals managing study around employment.
Some online or professionally focused programs may offer more frequent start dates or flexible entry points throughout the year. Students should not assume that every course has monthly or multiple intakes — availability depends on the institution, course structure and student type.
Graduates of the MPhil (Experimental Pharmacology) are equipped for a broad range of careers across Australia's growing pharmaceutical, biotechnology, medical research, and regulatory sectors. The degree is a recognised stepping stone to doctoral (PhD) study and academic research careers, while also providing strong credentials for roles in drug discovery, preclinical research, clinical trials, regulatory affairs, and scientific consulting. Employers include pharmaceutical multinationals, Australian biotech companies, contract research organisations (CROs), university research centres, government agencies such as the Therapeutic Goods Administration (TGA), hospital-based research institutes, and medical device companies. The combination of advanced laboratory skills, scientific rigour, and research communication ability makes MPhil graduates highly versatile in a sector that spans laboratory science, industry, and health policy.
Entry Level
Graduate Researcher / Research Assistant
Graduate Research Assistant, Laboratory Technician (Pharmacology), Junior Clinical Research Associate, Research Officer, Postgraduate Research Scholar
Early Career
Research Scientist / Associate
Research Scientist, Preclinical Scientist, Clinical Research Associate, Pharmacovigilance Officer, Regulatory Affairs Associate, Quality Assurance Scientist
Mid-Level
Senior Scientist / Specialist
Senior Research Scientist, Drug Discovery Specialist, Senior Regulatory Affairs Specialist, Medical Science Liaison, Translational Research Scientist, Senior CRA, Laboratory Manager
Senior Level
Principal Scientist / Research Manager
Principal Scientist, Research Program Manager, Head of Preclinical Research, Senior Medical Science Liaison, Associate Director Regulatory Affairs, Senior Toxicologist
Leadership
Director / Head of Research / Professor
Director of Research and Development, Head of Pharmacology, Chief Scientific Officer, Professor of Pharmacology, Vice President of Drug Discovery, Director of Regulatory Affairs
Salaries for experimental pharmacology graduates in Australia vary by role, sector, and experience level, with research-intensive and industry positions offering competitive remuneration.
Melbourne
Melbourne is a leading hub for pharmacological and biomedical research in Australia, home to globally recognised research institutes, major teaching hospitals, and a thriving pharmaceutical and biotechnology sector. The city offers students exceptional access to collaborative research environments, industry partners including CSL Behring and numerous biotech start-ups, and a vibrant scientific community centred around Parkville's world-class medical research precinct.
Sydney
Sydney hosts a highly active pharmaceutical and clinical research sector, with major multinational companies such as AstraZeneca, Pfizer, Roche, and Johnson & Johnson maintaining significant Australian operations in the city. Students benefit from strong links between universities, hospital research institutes, and contract research organisations, as well as access to one of Australia's largest and most diverse healthcare markets.
Brisbane
Brisbane is an emerging powerhouse for biomedical and pharmaceutical research, supported by a dynamic innovation ecosystem that includes biotech accelerators, university research centres, and a rapidly growing healthcare industry. The city's subtropical lifestyle, lower cost of living relative to Sydney and Melbourne, and strong government investment in health and science R&D make it an attractive destination for pharmacology researchers.
Perth
Perth offers a focused and well-supported research environment for pharmacological sciences, particularly in areas of tropical diseases, immunology, and Aboriginal and Torres Strait Islander health research. The city has strong connections to mining-related toxicology and occupational health research, as well as growing pharmaceutical and biotech industries supported by the Western Australian government's health innovation initiatives.
Adelaide
Adelaide is home to a compact but highly collaborative research community, with strong pharmacology programs supported by proximity to major teaching hospitals and health research institutes. The city's lower cost of living, close-knit scientific networks, and government support for health and medical research make it a practical and rewarding choice for MPhil students in experimental pharmacology.
Canberra
Canberra is uniquely positioned for pharmacology researchers interested in the intersection of science, health policy, and government regulation, given its proximity to federal agencies including the Therapeutic Goods Administration (TGA) and the National Health and Medical Research Council (NHMRC). The city's research universities and national scientific institutions offer distinctive opportunities for students interested in regulatory science, drug policy, and translational research.
Before choosing a course, students should compare:
International students who want to study in Australia should also consider additional requirements before applying.
Join successful graduates
Students Helped
Application Processed
Listed Universities
Listed Courses
